TOKYO -- SoftBank Group's Vision Fund has invested in a Japanese company for the first time, Nikkei has learned, as the tech investor accelerates a push for geographic diversity in its portfolio.
The Vision Fund led a 6.8 billion yen ($59.7 million) investment into Aculys Pharma, a biotech startup co-founded in January by Kazunari Tsunaba, the former president of the Japanese arm of Novartis.
